Inject air into the vial with the eye of the needle immersed in the fluid.
A small needle is used to inject a substance into the tissue layer separating the skin and the muscle during a subcutaneous injection to deliver medication.
The steps involved in giving a subcutaneous injection are:
- washing hands in warm water and soap.
- assembling the necessary tools, including alcohol pads, gauze, needles, and syringes.
- examination and cleaning of the injection site.
- Putting the drug in the syringe entails:
- the vial's cap is taken off.
- air being injected into the syringe.
- inflating the virus with air.
- medicine discontinuation
- eliminating air bubbles.
- distributing the medicine.
Here is another question with an answer similar to this about subcutaneous injection: brainly.com/question/4278546
#SPJ4
A Drug Trend report published in 2009 had predicted continued price increase among traditional branded and biotech drugs that lack generic competition. Now, further, CMS has reduced its Average Sales price (ASP) margin from 6 percent to 4 percent for non-pass-thorough. This has affected pharmacy reimbursement. However, there are certain other aspects of Pharmacy Billing that can affect reimbursement and thereby the Revenue Cycle Management (RCM) process if not well implemented.
1. Data Workflow:
Recognizing how the revenue cycle works in pharmacy is very essential. Procurement to Inventory, billing and reimbursement involves purchase of medications, their storage, and method of dispensing, how they are administered, way they are coded & billed, and finally reimbursed. If the drug is covered as a pharmacy benefit, or the payer needs that to be obtained via a specialty pharmacy as identified through patient-specific benefit verification, then here both the provider and the pharmacy are part of the reimbursement process. The physician writes a prescription and orders the drug. This is followed by the pharmacy that fills the order and issues the drug to the physician, CMHC, or hospital outpatient department. Here the pharmacy bills the insurance company for the drug. If any information is entered incorrectly into the pharmacy system in the initial phase of the cycle, errors can prove to be costly, impacting aspects of clinical and revenue cycle.
2. Procurement:
During this phase information is converted from purchased quantities and pricing to storage units of measure (UOM) and inventory costs. Manually entering the data is followed in most cases. UOM conversions, when data is uploaded from the wholesale distributor to the pharmacy system, are also checked and verified manually. Here too mistakes can lead to breakdown in the revenue cycle management (RCM) process.
3. The Charge master:
Critical & substantial revenue leakage can occur when separately reimbursable medications are either missing from or miscoded in the charge master. Conversion of pharmaceutical quantities is a must from purchased amounts to patient-administered amounts, and only then made billable. There is often a difference between dosage amounts required for patient use as from that purchased. Besides inventory, the clinician and pharmacist should convert dosage, strength, and delivery mechanism for each drug. Drug data must be correctly converted from the quantities residing in clinical systems into the payer-billable quantities appropriate for the financial system or charge master. The UOMs must be reconciled to avoid any under- or over-payments. More than often, missing or incorrect data in the charge master can result in negative financial consequences – denied claims, partial reimbursement, and compliance risks.
4. Linkages between Purchases & Billing:
Most hospitals have separate processes to order drugs, administer them, and process reimbursement. Without linkage between pharmacy expenditures for medications (i.e., spend data) and the charge master, ensuring proper charge capture and optimal reimbursement is a challenge. Besides hospitals should have automated tools to identify charge capture errors precisely, so as to pinpoint when and where their occurrence to decreasing revenue loss.
Answer:
The correct answer to the question: An abnormal sound (murmur) due to narrowing or stenosis of the mitral valve might be heard during:____, would be, A: Diastole.
Explanation:
It is first important to know that a murmur comes from the sound the blood makes as it passes either through a hardened tissue, like is the case of stenosis of a valve, or because it leaks back from where it came, due to regurgitation, because the valve is defective and cannot close properly. During the cardiac cycle, there is a process of systole, and of diastole, that ensure the filling and expulsion of the blood inside the heart towards the body, and from the body into the heart, so that a constant flow is ensured. In the process of filling and emptying, two sets of valves, the mitral and tricuspid, and the aortic and pulmonary, open and close to allow blood flow towards the different chambers of the heart, and out into the blood vessels of the body, and prevent the blood from returning towards where it came. In the case of mitral stenosis, which is the toughening of the mitral valve of the heart, the blood flowing through it makes a murmuring sound that can be caught up through a stethoscope. This sound is prominent during diastole, and that is why medically this murmur is known as a diastolic murmur.
Pain and swelling in the elbows.
Answer:
testes , testicular lobules , seminiferous
Explanation:
Gonads are the primary sex organs in the male which are the two testes.
Each testis is surrounded by the dense connective tissue capsule called tunica albuginea which is responsible for the thickening on the posterior side and forms mediastinum testis.
From this region, the septa penetrate and divide it into about 250 pyramidal compartments (testicular lobules) . Each lobule is containing the sparse connective tissue with the endocrine interstitial cells that secrets testosterone, and also contains one to four highly convoluted seminiferous tubules which is responsible for sperm production.
